Other groups indicated that aberrant activation of CCDC6 as an independent gene has been implicated in promoting tumour progression in multiple malignancies, including lung, gastric and bladder urothelial carcinoma [20, 21, 22]. The gene discussed is CCDC6; the disease is neoplasm.